2 terminated, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
Follow SHP640: new trials by email Literature Review of SHP640 trials Research Report on SHP640
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo SHP640, PVP-I 0.6%, Placebo - Bacterial Conjunctivitis | Phase 3 | Completed | Shire | 753 | 2017-03-29 | 2021-06-09 |
| Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo SHP640, Placebo - Adenoviral Conjunctivitis | Phase 3 | Terminated | Shire | 156 | 2017-03-28 | 2021-06-09 |
| Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo SHP640, PVP-I 0.6%, Placebo - Adenoviral Conjunctivitis | Phase 3 | Terminated | Shire | 219 | 2017-03-27 | 2021-06-14 |
Shire (3)
United States (3) · Australia (2) · Austria (2) · Canada (2) · Estonia (2) · France (2) · Hungary (2) · Israel (2) · Italy (2) · Poland (2) · Puerto Rico (2) · South Africa (2) · Spain (2) · Germany (1) · India (1)
2016 (3)